Jean-christophe C. Thery
Rouen, France
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 25 publications
Optimising rare tumour risk syndromes care: clinical insights and the PREVENTABLE socioeconomic framework.
Journal: European journal of human genetics : EJHG
Published: June 23, 2025
Deciphering dual clinical entities associated with TP53 pathogenic variants: Insights from 53,085 HBOC panel analyses in French laboratories.
Journal: International journal of cancer
Published: September 26, 2024
Multidisciplinary support in cancer care: Pair working physician/psychologist in the support of children of affected parents by cancer
Journal: Bulletin du cancer
Published: February 08, 2024
Pertuzumab Plus Trastuzumab With or Without Chemotherapy Followed by Emtansine in ERBB2-Positive Metastatic Breast Cancer: A Secondary Analysis of a Randomized Clinical Trial.
Journal: JAMA oncology
Published: August 10, 2023
Disequilibrium between BRCA1 and BRCA2 Circular and Messenger RNAs Plays a Role in Breast Cancer.
Journal: Cancers
Published: March 16, 2023
Adjuvant trastuzumab emtansine in HER2-positive breast cancer patients with HER2-negative residual invasive disease in KATHERINE.
Journal: NPJ breast cancer
Published: March 10, 2022
Outcomes of patients with HER2-negative metastatic breast cancer after platinum- and non-platinum-based first-line chemotherapy among patients with and without pathogenic germline BRCA1/2 mutations.
Journal: British journal of cancer
Published: March 04, 2022
Genomics to select treatment for patients with metastatic breast cancer.
Journal: Nature
Published: October 24, 2021
Impact of lobular versus ductal histology on overall survival in metastatic breast cancer: a French retrospective multicentre cohort study.
Journal: European journal of cancer (Oxford, England : 1990)
Published: October 12, 2021
Durvalumab compared to maintenance chemotherapy in metastatic breast cancer: the randomized phase II SAFIR02-BREAST IMMUNO trial.
Journal: Nature medicine
Published: May 29, 2020
Randomised phase II trial evaluating the safety of peripherally inserted catheters versus implanted port catheters during adjuvant chemotherapy in patients with early breast cancer.
Journal: European journal of cancer (Oxford, England : 1990)
Published: September 11, 2019
Last Updated: 09/26/2026